Overcoming zero-sum thinking to advance US population health

IF 50 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Vincent Guilamo-Ramos, Marco Thimm-Kaiser, Adam Benzekri, Daniel E. Dawes
{"title":"Overcoming zero-sum thinking to advance US population health","authors":"Vincent Guilamo-Ramos, Marco Thimm-Kaiser, Adam Benzekri, Daniel E. Dawes","doi":"10.1038/s41591-025-03907-0","DOIUrl":null,"url":null,"abstract":"<p>There is broad consensus that the US healthcare system is failing. Policy initiatives to reduce costs and improve healthcare outcomes have been longstanding priorities across presidential administrations, but there has been limited success. The USA continues to achieve worse outcomes than those of comparable high-income countries while spending more on healthcare<sup>1</sup>.</p><p>One important factor preventing reforms is zero-sum thinking about health inequities: the belief that investing to improve the health of population segments with the worst outcomes comes at the expense of those with better baseline health<sup>2</sup>. Here we challenge the zero-sum thinking that denies the broader, population-level benefits of eliminating health inequities. First, we show how health inequities harm the whole US population, not just marginalized groups, highlighting how reducing inequities benefits everyone. Second, we identify four common fallacies in healthcare-related zero-sum thinking and counter each. Finally, we argue the importance of overcoming zero-sum thinking for advancing substantive healthcare reforms.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"9 1","pages":""},"PeriodicalIF":50.0000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03907-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There is broad consensus that the US healthcare system is failing. Policy initiatives to reduce costs and improve healthcare outcomes have been longstanding priorities across presidential administrations, but there has been limited success. The USA continues to achieve worse outcomes than those of comparable high-income countries while spending more on healthcare1.

One important factor preventing reforms is zero-sum thinking about health inequities: the belief that investing to improve the health of population segments with the worst outcomes comes at the expense of those with better baseline health2. Here we challenge the zero-sum thinking that denies the broader, population-level benefits of eliminating health inequities. First, we show how health inequities harm the whole US population, not just marginalized groups, highlighting how reducing inequities benefits everyone. Second, we identify four common fallacies in healthcare-related zero-sum thinking and counter each. Finally, we argue the importance of overcoming zero-sum thinking for advancing substantive healthcare reforms.

克服零和思维,促进美国人口健康
人们普遍认为,美国的医疗体系正在失灵。降低成本和改善医疗保健结果的政策举措一直是历届总统政府的优先事项,但取得的成功有限。尽管美国在医疗保健方面的支出更多,但其医疗保健结果仍比可比的高收入国家差。阻碍改革的一个重要因素是对卫生不平等的零和思维:认为投资于改善结果最差的人群的健康,是以牺牲基线健康状况较好的人群为代价的。在这里,我们挑战零和思维,这种思维否定了消除卫生不平等所带来的更广泛的、人口层面的好处。首先,我们展示了卫生不平等如何损害整个美国人口,而不仅仅是边缘化群体,强调减少不平等如何使每个人受益。其次,我们找出了与医疗保健相关的零和思维中的四个常见谬误,并一一反驳。最后,我们论证了克服零和思维对于推进实质性医疗改革的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信